Ferroptosis: How Cells Die When Iron Goes Wrong

Your cells contain iron. Not much of it, but it’s there, tucked inside proteins and organelles, doing essential work. Oxygen transport. Energy production. DNA synthesis. Yet iron has a dangerous side. Under the right conditions, it becomes a weapon that cells deliberately use against themselves through a process called ferroptosis. Unlike other forms of cell death, ferroptosis is triggered specifically by iron-dependent chemistry, and it’s controlled in ways that cancer cells and treatment-resistant infections might find problematic. Scientists are realising this mechanism matters far more than anyone expected.

What is ferroptosis

Ferroptosis is controlled cell death driven by iron and reactive oxygen species. Here’s the mechanism: iron exists in two oxidation states in cells, ferrous (Fe2+) and ferric (Fe3+). The ferrous form is unstable. When it encounters hydrogen peroxide or lipid peroxides already floating around the cell, it catalyses the Fenton reaction, a chemical process that generates highly reactive hydroxyl radicals. These radicals are indiscriminate destroyers. They shred through lipid membranes, particularly the polyunsaturated lipids that give cell membranes their flexibility.

What makes ferroptosis distinct from other cell death pathways is that it doesn’t rely on the usual suspects. No caspases cleaving proteins. No mitochondrial collapse triggering apoptosis. Instead, ferroptosis is a lipid-peroxidation driven catastrophe that cells can actually prevent using specific defence systems. The main one is the selenoprotein glutathione peroxidase 4, or GPX4. Think of GPX4 as a highly specialised repair crew. It uses glutathione as a chemical substrate to neutralise lipid peroxides before they accumulate. Remove this system or starve it of resources, and ferroptosis becomes inevitable.

What the research shows

When researchers suppress GPX4 or its glutathione supply, cells rapidly accumulate lipid peroxides and die within hours. But here’s what’s interesting: the cells dying this way show specific, reproducible signatures. Their mitochondria shrink. Their cell membrane becomes permeable. They release damage-associated molecules that trigger inflammation in surrounding tissue. This isn’t passive cell death. It’s coordinated. Cells appear to sense iron levels and peroxide accumulation and then execute ferroptosis as an active choice.

The research also reveals that different cell types have different sensitivities to ferroptosis. Neurons are remarkably resistant. They maintain robust GPX4 expression and high glutathione availability. Cancer cells, by contrast, often show increased iron accumulation and reduced antioxidant defences, making them vulnerable to ferroptosis triggers. Certain leukaemia cells die rapidly when ferroptosis is induced. Some drug-resistant lung cancer cells can be pushed toward ferroptosis when conventional treatments fail. This isn’t universal across all cancers, but the pattern keeps emerging across multiple studies.

Environmental factors also modulate ferroptosis sensitivity. Nutritional iron status clearly matters. Cells starved of iron can’t undergo ferroptosis because they lack the raw material. Iron overload, conversely, sensitises cells to ferroptosis. Vitamin E and other lipophilic antioxidants provide some protection. Even diet composition, particularly polyunsaturated fat intake, influences how readily cells can accumulate the lipid peroxides that drive the process.

Why cells need this

Why would evolution preserve a suicide switch triggered by iron chemistry? The answer lies in infection defence and tissue quality control. Many bacteria and parasites depend on iron acquisition to establish infection. If a cell detects pathogenic iron sequestration or senses that pathogens are hijacking its iron metabolism, inducing ferroptosis might be preferable to becoming a replication factory for invaders. It’s the cell equivalent of a scorched earth policy. Better to die in a controlled, coordinated way than become a vector for systemic infection.

Ferroptosis also likely functions as a failsafe when other protective systems are overwhelmed. If a cell sustains damage that compromises its antioxidant defences, if its mitochondria are producing excessive free radicals, or if iron homeostasis collapses, ferroptosis ensures that cell doesn’t linger in a damaged, potentially dangerous state. This prevents genomic instability from becoming heritable mutation. It removes cells that might otherwise progress toward malignant transformation. The system isn’t pretty, but it’s efficient.

There’s also emerging evidence that ferroptosis serves in tissue remodelling and developmental processes. During certain phases of neural development, ferroptosis-sensitive cells are selectively eliminated. In tissue scarring and fibrosis, ferroptosis may limit fibroblast accumulation. The pathway appears deeply woven into normal physiology, not just disease response.

What affects ferroptosis

Iron metabolism sits at the centre. Hepcidin, the hormone that controls iron absorption and storage, influences cellular iron levels. Transferrin receptor expression determines how much iron enters cells. Iron regulatory proteins sense intracellular iron and adjust gene expression accordingly. All of these factors directly impact ferroptosis sensitivity.

Lipid composition matters profoundly. Cells high in polyunsaturated fatty acids accumulate peroxides more readily and die faster when ferroptosis is triggered. Cells rich in saturated or monounsaturated fats show more resistance. This suggests that dietary fat profile could modulate ferroptosis sensitivity, though this remains incompletely understood in living organisms.

Antioxidant availability is another key variable. Glutathione synthesis depends on adequate cysteine and glycine. Selenium availability limits GPX4 synthesis. Vitamin E concentration in membranes provides direct lipid radical scavenging. Ageing typically reduces all of these. Chronic inflammation tends to deplete glutathione while increasing basal lipid peroxide levels. Certain medications inhibit GPX4 or glutathione synthesis. Even stress hormones appear to modulate the pathway, though the mechanisms remain unclear.

What remains unknown

The biggest gap is understanding ferroptosis regulation in living organisms. Most ferroptosis research happens in cell culture, where conditions are controlled and artificial. How does ferroptosis actually function within tissues? Which ferroptosis-triggering factors matter most in vivo? Do different tissues rely on ferroptosis for different purposes, and if so, how do they maintain cell-type specific sensitivities?

Scientists are also puzzled by the relationship between ferroptosis and inflammation. When ferroptosis occurs, cells release molecules that trigger immune responses. Is this a feature or a bug? Does ferroptosis-induced inflammation serve a protective function against pathogens, or does it contribute to chronic inflammatory disease? The data aren’t clear yet.

There’s also the question of ferroptosis’s role in age-related disease. Ageing involves reduced antioxidant capacity and accumulating oxidative damage. Does ferroptosis contribute to neurodegeneration, cardiovascular disease, or metabolic decline? Some preliminary evidence suggests connections, but proving causation requires tools researchers are still developing. And the question of whether ferroptosis sensitivity increases or decreases with age remains surprisingly unsettled across different tissue types.

Ferroptosis sits at the intersection of iron chemistry, membrane biology, and cell death signalling. It’s a reminder that cell death isn’t a malfunction to prevent at all costs. Controlled, purposeful cell death is central to health, and understanding the specific mechanisms cells use to eliminate themselves reveals something fundamental about how organisms maintain integrity. As research advances, ferroptosis might become another lever for understanding why some cells resist death they shouldn’t, and others die when they should survive.